Synbiotics in Metabolic Disorders: Mechanisms, Therapeutic Potential, and Future Perspectives | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Arshad Farid
B01=Ashish Garg
B01=Neeraj Mishra
B01=Sumel Ashique
Category1=Non-Fiction
Category=MBNH3
Category=MJG
Category=TDCT
Category=TDCW
COP=United Kingdom
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€100 and above
PS=Forthcoming
softlaunch

Synbiotics in Metabolic Disorders: Mechanisms, Therapeutic Potential, and Future Perspectives

English

This book explores the potential role of prebiotics, probiotics, and synbiotics in managing various metabolic disorders, chronic diseases, and metabolic syndromes. The initial chapter provides an overview of metabolic disorders, including their classification, symptoms, and underlying causes. Additionally, the chapter discusses the intricate signaling pathways and mechanisms through which prebiotics, probiotics, and synbiotics interact with the human body in relation to type-2 diabetes, obesity, Phenylketonuria, and Hemochromatosis. Additionally, the book highlights the potential impact of probiotics and synbiotics on oxidative stress, inflammation, lipid metabolism, and blood pressure. Furthermore, this book focuses on the gut-brain axis and how synbiotics may influence neurotransmitter metabolism. With an emphasis on the gut-microbiota axis, this book presents a compelling narrative that explores the rationality behind synbiotic use and offers a glimpse into future perspectives for managing metabolic disorders effectively. This book is intended for researchers in the fields of nutraceuticals, nanomedicine, endocrinology, nutrition, gastroenterology, and metabolic medicine who are working in the field of probiotics, prebiotics, and symbiotics for the treatment of metabolic disorders.

See more
Current price €136.79
Original price €143.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Arshad FaridB01=Ashish GargB01=Neeraj MishraB01=Sumel AshiqueCategory1=Non-FictionCategory=MBNH3Category=MJGCategory=TDCTCategory=TDCWCOP=United KingdomDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€100 and abovePS=Forthcomingsoftlaunch

Will deliver when available. Publication date 31 Oct 2024

Product Details
  • Dimensions: 210 x 280mm
  • Publication Date: 27 Nov 2024
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9781032702414

About

Dr. Neeraj Mishra has been working as a Professor at Amity Institute of Pharmacy Gwalior since July 2019. He has around 20 years of teaching and research experience. He has more than 100 publications of international and national repute on recent concepts of novel drug delivery systems oral delivery of synbiotics localized drug delivery and targeted and controlled drug delivery of nanocarriers and microparticles for the treatment of breast colon and neurodegenerative disorders. He has also edited 10 books and authored 25 book chapters. He has been granted three international patents and two Indian patents. Dr. Mishra is the recipient of the Distinguished Professor Award 2019 from DST-NSTMIS SPAICS Indore and M.P. in September 2019. Dr. Mishra has also received the Outstanding Scientist Award ' 2020 6th International Scientist Awards on Engineering Science and Medicine 2021 June 2020 Chennai India. Dr. Mishra has received the Distinguished Professor Award ' 2021 from the Indian Pharmaceutical Association MP State Branch Indore. Dr. Mishra has received the Best Academician Award in the Indian Pharmacy Graduate Association M.P. State International Conference held on May 6 2023 at DAVV Auditorium Indore India.Dr. Sumel Ashique has been working as an Assistant Professor at the Department of Pharmaceutical Sciences Bengal College of Pharmaceutical Sciences & Research Durgapur 713212 West Bengal India. He has 3.5 years of teaching experience and has published more than 50 research studies and review articles in internationally and nationally accredited reputed journals. He has been working in targeted drug delivery nanotechnology and gut microbiome. He has also been granted 5 patents from IP and Australia and has authored more than 20 book chapters. He has edited 5 books under CRC Press Springer Wiley and Taylor-Francis Publisher.Dr. Arshad Farid is a distinguished academic and researcher with a prolific career spanning over 15 years in teaching and research. He is currently serving as an Assistant Professor in the Gomal Center of Biochemistry and Biotechnology at Gomal University Pakistan. He completed his Ph.D. in Biotechnology from the Centre of Biotechnology and Microbiology (COBAM) University of Peshawar Pakistan. His remarkable achievements have garnered him international recognition as evidenced by his selection for the British Council-Charles Wallace Fellowship program for the academic year 2022-2023. In 2007 he was also awarded a prestigious scholarship to the University of Glasgow UK funded by the Higher Education Commission (HEC) of Pakistan. He has authored or co-authored more than 70 research papers and has been granted nine patents.Dr. Ashish Garg obtained a B. Pharm. in 2011 and a M. Pharm. in 2013 from Guru Ramdas Khalsa Institute of Science and Technology Pharmacy Jabalpur M.P. India. He has pursued his Ph.D. from SRK University M.P. He has over 10 years of experience in both teaching and research. He has authored more than 100 research and review articles published in national and international journals of high repute. Additionally he has edited ten books and been awarded three patents and one design patent. He is presently working as an Associate Professor in the Department of Pharmaceutics at Guru Ramdas Khalsa Institute of Science and Technology Jabalpur Madhya Pradesh India.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept